COVID-19-associated blood plasma inflammatory factors do not affect blood-brain barrier, study shows

It is now well documented that the coronavirus outbreak triggered a global health crisis. In this study, researchers wanted to know whether blood-brain barrier impairment contributed to the development of neurological problems during COVID-19 progression, and to what extent.

UCB debuts first campaign for psoriasis drug Bimzelx during Oscars

UCB gave psoriasis drug Bimzelx a red-carpet campaign launch, debuting its direct-to-consumer advertising during the 96th Academy Awards on Sunday. The campaign for the IL-17

March 12, 2024

Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

May 6, 2024

Scientists demonstrate way to produce SARS-CoV-2 receptor protein in mouse cells

A team of scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory and Columbia University has demonstrated a way to produce large quantities

January 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.